Expression of urokinase plasminogen activator receptor on monocytes from patients with relapsing-remitting multiple sclerosis: effect of glatiramer acetate (copolymer 1).

导出原文传递

翻译打印收藏纠错

作者： Balabanov R ^[1] ; Lisak D ^[2] ; Beaumont T ; Lisak RP ; Dore-Duffy P

作者单位： ost.tau.ac.il ^[1] Multiple Sclerosis Clinical Research Center, Department of Neurology, Division of Neuroimmunology, Wayne State University School of Medicine, Detroit Medical Center, Detroit, Michigan 48201, USA. ^[2]

关键词 Immunosuppressive Agents Monocytes Multiple Sclerosis Relapsing Remitting drug therapy 免疫抑制剂单核细胞肽类受体细胞表面

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical and diagnostic laboratory immunology

2001年8卷6期

1196-1203页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Expression of urokinase plasminogen activator receptor on monocytes from patients with relapsing-remitting multiple sclerosis: effect of glatiramer acetate (copolymer 1).

Clinical and diagnostic laboratory immunology

相似文献

Clinical and diagnostic laboratory immunology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Expression of urokinase plasminogen activator receptor on monocytes from patients with relapsing-remitting multiple sclerosis: effect of glatiramer acetate (copolymer 1).

Clinical and diagnostic laboratory immunology

相似文献

Clinical and diagnostic laboratory immunology

相关期刊

检索历史清除